Omega Healthcare’s 2024 Year-End Performance Summary
Omega Healthcare Investors, Inc. (NYSE: OHI) is pleased to report its financial results for the fourth quarter and full year of 2024. This report provides an overview of our net income, funds from operations, and a summary of significant activities during the year.
Fourth Quarter Highlights
Strong Financial Growth
During the fourth quarter of 2024, Omega reported a net income of $116 million, translating to $0.41 per common share. This compares favorably to $57 million, or $0.22 per common share, reported in the same period of 2023. Our performance demonstrates a substantial year-over-year increase, underlining the strategic investments and operational efficiencies we have implemented.
Funds from Operations
We achieved Nareit Funds From Operations (FFO) of $196 million, equivalent to $0.68 per common share, based on 287 million weighted-average shares outstanding. This represents a significant increase from $129 million, or $0.50 per common share, for the same quarter last year. Adjusted FFO reached $214 million, or $0.74 per common share, further highlighting the strength of our operational model in a competitive market.
Investment Activity
In the last quarter alone, we completed approximately $340 million in new investments, comprising $179 million in real estate acquisitions and $162 million in real estate loans. This proactive approach allowed us to assertively grow our portfolio while maintaining high occupancy levels.
2024 Annual Performance Overview
Annual Financial Results
For the full year 2024, Omega reported a net income of $418 million, or $1.55 per common share, marking an increase from $249 million or $1.00 per common share in 2023. The Nareit FFO for the entire year was reported at $734 million, reflecting an increase to $2.71 per common share from $591 million, or $2.36 per share, in 2023.
Capital Investments and Strategy
Throughout 2024, we achieved $1.1 billion in new investments, which included $696 million in real estate acquisitions and $359 million in real estate loans. These investments have played a critical role in optimizing our asset base and enhancing our service delivery.
Operational Improvements
We're proud to report that our funds available for distribution (FAD) increased to $739 million, equating to $2.73 per common share. This improvement is attributable to our strategic focus on reducing the payout ratio while enhancing shareholder value through thoughtful investments.
CEO Insights
Taylor Pickett, our CEO, commented on the strong performance, stating, “2024 has been a transformative year for Omega, where we have not only increased FAD per share but also improved our overall leverage position.” He further noted the favorable operating conditions and ongoing improvement in occupancy rates across the portfolio.
Looking Ahead: 2025 Guidance
As we set our sights on 2025, Omega anticipates maintaining a strong performance with Adjusted FFO projected between $2.90 and $2.98 per diluted share. This guidance reflects the ongoing effects of strategic acquisitions made in recent years along with prudent cash management practices.
Balance Sheet and Liquidity Position
As of December 31, 2024, we maintained a solid balance sheet with total indebtedness of $4.9 billion at a weighted-average interest rate of 4.6%. With $518.3 million in cash and equivalents, coupled with a robust undrawn revolving credit facility, we are well-positioned to handle future growth endeavors.
Conference Call Announcement
Omega will hold a conference call on February 6, 2025, at 10 a.m. Eastern Time to discuss the fourth quarter results in further detail. Interested parties are encouraged to join us for insights into our operational strategies and future outlook.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) that specializes in providing financing and property investment solutions within the long-term healthcare sector, including skilled nursing and assisted living facilities throughout the United States and the United Kingdom.
Frequently Asked Questions
What were Omega's fourth quarter earnings in 2024?
Omega reported a net income of $116 million, or $0.41 per common share for the fourth quarter of 2024.
How did Omega's annual performance compare to 2023?
In 2024, Omega's net income increased to $418 million from $249 million in 2023, showcasing significant growth.
What are Nareit FFO and Adjusted FFO for Omega?
For 2024, Nareit FFO was $734 million, while Adjusted FFO reached $778 million.
Is Omega planning to increase its dividend in 2025?
While specific plans for future dividends have not yet been disclosed, Omega declared a quarterly cash dividend of $0.67 per share in January 2025.
Where can investors learn more about Omega Healthcare?
For more information, investors can visit Omega's website or refer to the latest financial supplements provided in their Investor Relations section.
